0R7 Stock Overview
Produces and sells perfumes, aromas, and natural products. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Robertet SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €952.00 |
52 Week High | €961.00 |
52 Week Low | €751.00 |
Beta | 0.33 |
11 Month Change | -0.52% |
3 Month Change | 13.47% |
1 Year Change | n/a |
33 Year Change | -2.26% |
5 Year Change | 0% |
Change since IPO | 138.61% |
Recent News & Updates
Recent updates
Shareholder Returns
0R7 | DE Chemicals | DE Market | |
---|---|---|---|
7D | 0% | -3.2% | -1.5% |
1Y | n/a | -1.1% | 7.9% |
Return vs Industry: Insufficient data to determine how 0R7 performed against the German Chemicals industry.
Return vs Market: Insufficient data to determine how 0R7 performed against the German Market.
Price Volatility
0R7 volatility | |
---|---|
0R7 Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0R7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 0R7's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1850 | 2,153 | Jerome Bruhat | www.robertet.com |
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients.
Robertet SA Fundamentals Summary
0R7 fundamental statistics | |
---|---|
Market cap | €1.81b |
Earnings (TTM) | €86.35m |
Revenue (TTM) | €759.29m |
21.0x
P/E Ratio2.4x
P/S RatioIs 0R7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0R7 income statement (TTM) | |
---|---|
Revenue | €759.29m |
Cost of Revenue | €336.45m |
Gross Profit | €422.84m |
Other Expenses | €336.49m |
Earnings | €86.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 41.34 |
Gross Margin | 55.69% |
Net Profit Margin | 11.37% |
Debt/Equity Ratio | 61.8% |
How did 0R7 perform over the long term?
See historical performance and comparison